LogoLogo
  • Technology
  • Events
  • Company
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
SearchSearch
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
SearchSearch
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Logo

Discover Tixel® powered by TMA® technology. Revolutionary fractional skin resurfacing with maximum safety, minimal side effects. Quick, effective treatments for aesthetic and dry eye applications.

Support
  • Get Support
  • Request a Demo
Product
  • Aesthetics
  • Vision
Company
  • About the Company
  • Contact Us
  • Events
Resources
  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials
Legal
  • Intellectual Property
  • Counterfeit Devices Warning
Regulation
  • Quality Assurance
  • Regulatory Updates

Product

  • Aesthetics
  • Vision

Company

  • About the Company
  • Contact Us
  • Events

Resources

  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials

Support

  • Get Support
  • Request a Demo

Legal

  • Intellectual Property
  • Counterfeit Devices Warning

Regulation

  • Quality Assurance
  • Regulatory Updates

Newsletter

Stay updated with our latest Tixel news.

© 2026 Tixel®, Novoxel®, and TMA®. All rights reserved.

Privacy policyCookie preferences
  1. Clinical Publications
  2. /
  3. Retrospective Study on the Safety and Tolerability of Clinical Treatments with a Novel Thermomechanical Ablation Device on 150 Patients
Peer-reviewed paper

Retrospective Study on the Safety and Tolerability of Clinical Treatments with a Novel Thermomechanical Ablation Device on 150 Patients

Authors
Harryono Judodihardjo, Sajjad Rajpar
Journal
PubMed
Published
June 6, 2021
View publication

Opens in a new tab.

← View all Clinical Publications